Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes (source: FDA (2015)) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9620 | alirocumab |
Synonyms ![]() |
| Praluent® |
| REGN727 |
| SAR-236553 |
| SAR236553 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 412 |
| Other databases | |
| PubChem SID | 178103355 |
| Search PubMed clinical trials | alirocumab |
| Search PubMed titles | alirocumab |
| Search PubMed titles/abstracts | alirocumab |
| Wikipedia | Alirocumab |
| Comments |
| Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Based on peptide sequence matches we presume alirocumab is H1H316P in the patent document [4]. |